Real stories that help make ADHD more

relatable

Hear from other adults taking Qelbree for ADHD


It’s one thing to learn about ADHD—it’s another to live with it. Watch the videos below to hear from other adults living with ADHD, including their personal journeys to diagnosis and what’s changed since starting Qelbree.

Busy Philipps’ Story

“For me, Qelbree was the answer”

– Busy Philipps

As an actress, author, and mother of two, Busy Philipps found herself struggling to manage her daily tasks—but it wasn’t until her own daughter was diagnosed with ADHD that she discovered she was living with the condition, as well. After discovering Qelbree, hear how Busy is using her platform to help other women just like her better understand ADHD, and find the right treatment for them.

Jay Glazer’s Story

“My experience with Qelbree has inspired me to raise awareness”

– Jay Glazer

Before television personality and sports reporter Jay Glazer had his name in lights, he was a college freshman struggling with ADHD. Learn more about how Jay’s journey with ADHD led him to finding treatment with Qelbree.

Sam’s Story

“ADHD can be more manageable”

– Sam

When Sam entered the workforce as an adult, he experienced challenges with symptoms from ADHD. With the support of his healthcare provider, Sam found that ADHD can be more manageable with a diagnosis and treatment with Qelbree. Hear how Sam uses his experience to help others navigate ADHD treatment.

Amanda’s Story

“People didn’t really know I was struggling”

– Amanda

Though Amanda had struggled with ADHD symptoms most of her life, she reached a tipping point when the demands of work and motherhood felt like too much to manage. After discussing medication options with her doctor, Amanda finally found the treatment for her. See why Qelbree was such a turning point for Amanda, and how she’s progressed today.

Megan’s Story

“ADHD doesn’t have to control your life. It can be managed”

– Megan

From legal cases to laundry piles, Megan—a litigation paralegal—had always struggled to feel in control of her symptoms, now known to be from ADHD. Hear how her diagnosis at the age of 28 brought clarity to her struggles, and how non-stimulant Qelbree gives her the symptom support she needs to take control back.

Michele’s Story

“When I started Qelbree, the cloud lifted”

– Michele

From grade school to college to motherhood, Michele has felt the impacts of ADHD. But it wasn’t until her 10-year-old son was diagnosed with ADHD that she was diagnosed, too. Now they both take Qelbree for ADHD. Hear why starting treatment was such a turning point for Michele and her family.

Ashley’s Story

“Things can get better...keep pushing”

– Ashley

Despite having struggled with symptoms of ADHD since childhood, Ashley wasn’t officially diagnosed until she was an adult. Hear why having a diagnosis was so important for Ashley, and what sparked her treatment journey from stimulant medication to non-stimulant Qelbree.

David’s Story

“Qelbree gives adults with ADHD another option”

– David

When David started experiencing issues with his stimulant ADHD medication, he and his doctor knew it was time for a change. Hear how non-stimulant Qelbree helps manage David’s ADHD symptoms today, and what improvements he’s seen at work and at home.

We want to hear YOUR story

Have a Qelbree success story you’d like to share? We want to hear it! Whether it’s you taking Qelbree or someone you care for, your experience could help others more than you realize. Just email olivia@mypatientstory.com to find out more.

Note: Qualified candidates will be compensated for their involvement and time; not all candidates will be selected to participate.

Send an email

Ready to talk to your doctor?

If you’re ready to ask about Qelbree, we’ve got your back.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat ADHD in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide including Boxed Warning.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat ADHD in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide including Boxed Warning.